Therefore, our results suggest that Reishi’s anti-cancer effect is not exclusively through eIF4G downregulation, but likely occurs through an inhibitory combination of signaling pathways that include PI3K and mTOR pathways and on levels/activity of eIF4F complex proteins. Here, EIF4E is linked to cancer.